S

SciNeuro Pharmaceuticals

21 employees

SciNeuro is a biotechnology company focused on developing innovative medicines for patients with central nervous system diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neuroscience
Biopharma

Date founded

2020

Funding rounds raised

Total raised

$100M

from 4 investors over 4 rounds

S

SciNeuro Pharmaceuticals raised $100M on December 8, 2020

Investors: 泰福资本 TF Capital, Lilly Asia Ventures, Sequoia Capital China and Boyu Capital

FAQ